Literature DB >> 23658019

Interleukin-17 (IL-17) and IL-1 activate translation of overlapping sets of mRNAs, including that of the negative regulator of inflammation, MCPIP1.

Sonam Dhamija1, Reinhard Winzen, Anneke Doerrie, Gesine Behrens, Nancy Kuehne, Celina Schauerte, Elena Neumann, Oliver Dittrich-Breiholz, Michael Kracht, Helmut Holtmann.   

Abstract

Changes in gene expression during inflammation are in part caused by post-transcriptional mechanisms. A transcriptome-wide screen for changes in ribosome occupancy indicated that the inflammatory cytokine IL-17 activates translation of a group of mRNAs that overlaps partially with those affected similarly by IL-1. Included are mRNAs of IκBζ and of MCPIP1, important regulators of the quality and course of immune and inflammatory responses. Evidence for increased ribosome association of these mRNAs was also obtained in LPS-activated RAW264.7 macrophages and human peripheral blood mononuclear cells. Like IL-1, IL-17 activated translation of IκBζ mRNA by counteracting the function of a translational silencing element in its 3'-UTR defined previously. Translational silencing of MCPIP1 mRNA in unstimulated cells resulted from the combined suppressive activities of its 5'-UTR, which contains upstream open reading frames, and of its 3'-UTR, which silences independently of the 5'-UTR. Only the silencing function of the 3'-UTR was counteracted by IL-17 as well as by IL-1. Translational silencing by the 3'-UTR was dependent on a putative stem-loop-forming region previously associated with rapid degradation of the mRNA. The results suggest that translational control exerted by IL-1 and IL-17 plays an important role in the coordination of an inflammatory reaction.

Entities:  

Keywords:  Cytokine; IL-1; IL-17; Inflammation; MCPIP1; MRNA Decay; Translation; mRNA

Mesh:

Substances:

Year:  2013        PMID: 23658019      PMCID: PMC3696695          DOI: 10.1074/jbc.M113.452649

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  IL-17 enhances chemokine gene expression through mRNA stabilization.

Authors:  Justin Hartupee; Caini Liu; Michael Novotny; Xiaoxia Li; Thomas Hamilton
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

3.  A cis-element in the 3'-untranslated region of IkappaB-zeta mRNA governs its stimulus-specific expression.

Authors:  Satoshi Watanabe; Koichiro Takeshige; Tatsushi Muta
Journal:  Biochem Biophys Res Commun       Date:  2007-03-16       Impact factor: 3.575

4.  Stimulus-specific induction of a novel nuclear factor-kappaB regulator, IkappaB-zeta, via Toll/Interleukin-1 receptor is mediated by mRNA stabilization.

Authors:  Soh Yamazaki; Tatsushi Muta; Susumu Matsuo; Koichiro Takeshige
Journal:  J Biol Chem       Date:  2004-11-02       Impact factor: 5.157

5.  The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism.

Authors:  R Winzen; M Kracht; B Ritter; A Wilhelm; C Y Chen; A B Shyu; M Müller; M Gaestel; K Resch; H Holtmann
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

6.  A broader role for AU-rich element-mediated mRNA turnover revealed by a new transcriptional pulse strategy.

Authors:  N Xu; P Loflin; C Y Chen; A B Shyu
Journal:  Nucleic Acids Res       Date:  1998-01-15       Impact factor: 16.971

7.  Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP).

Authors:  Jianli Niu; Asim Azfer; Olga Zhelyabovska; Sumbul Fatma; Pappachan E Kolattukudy
Journal:  J Biol Chem       Date:  2008-03-24       Impact factor: 5.157

8.  A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages.

Authors:  Jian Liang; Jing Wang; Asim Azfer; Wenjun Song; Gail Tromp; Pappachan E Kolattukudy; Mingui Fu
Journal:  J Biol Chem       Date:  2008-01-04       Impact factor: 5.157

9.  Functional analysis of KSRP interaction with the AU-rich element of interleukin-8 and identification of inflammatory mRNA targets.

Authors:  Reinhard Winzen; Basant Kumar Thakur; Oliver Dittrich-Breiholz; Meera Shah; Natalie Redich; Sonam Dhamija; Michael Kracht; Helmut Holtmann
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

10.  Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction.

Authors:  Limei Zhou; Asim Azfer; Jianli Niu; Sarabeth Graham; Mahua Choudhury; Frances M Adamski; Craig Younce; Phillip F Binkley; Pappachan E Kolattukudy
Journal:  Circ Res       Date:  2006-03-30       Impact factor: 17.367

View more
  12 in total

1.  MCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation.

Authors:  Leticia Monin; Johann E Gudjonsson; Erin E Childs; Nilesh Amatya; Xianying Xing; Akash H Verma; Bianca M Coleman; Abhishek V Garg; Meaghan Killeen; Alicia Mathers; Nicole L Ward; Sarah L Gaffen
Journal:  J Immunol       Date:  2016-12-05       Impact factor: 5.422

Review 2.  Translational control of immune responses: from transcripts to translatomes.

Authors:  Ciriaco A Piccirillo; Eva Bjur; Ivan Topisirovic; Nahum Sonenberg; Ola Larsson
Journal:  Nat Immunol       Date:  2014-06       Impact factor: 25.606

Review 3.  RNA-binding proteins in immune regulation: a focus on CCCH zinc finger proteins.

Authors:  Mingui Fu; Perry J Blackshear
Journal:  Nat Rev Immunol       Date:  2016-12-19       Impact factor: 53.106

4.  MCPIP1 alleviated alcohol-induced immune dysfunction via the MAPK/ERK signaling pathway.

Authors:  Yanjie Shen; Kai Zhang; Rui Wang; Shuaichen Sun; Yating Yang; Yitan Yao; Huanzhong Liu; Zhenhua Ren
Journal:  Psychopharmacology (Berl)       Date:  2022-09-21       Impact factor: 4.415

5.  MCPIP1 Endoribonuclease Activity Negatively Regulates Interleukin-17-Mediated Signaling and Inflammation.

Authors:  Abhishek V Garg; Nilesh Amatya; Kong Chen; J Agustin Cruz; Prerna Grover; Natasha Whibley; Heather R Conti; Gerard Hernandez Mir; Tatiana Sirakova; Erin C Childs; Thomas E Smithgall; Partha S Biswas; Jay K Kolls; Mandy J McGeachy; Pappachan E Kolattukudy; Sarah L Gaffen
Journal:  Immunity       Date:  2015-08-25       Impact factor: 31.745

6.  IL-17 integrates multiple self-reinforcing, feed-forward mechanisms through the RNA binding protein Arid5a.

Authors:  Nilesh Amatya; Erin E Childs; J Agustin Cruz; Felix E Y Aggor; Abhishek V Garg; Andrea J Berman; Johann E Gudjonsson; Ulus Atasoy; Sarah L Gaffen
Journal:  Sci Signal       Date:  2018-10-09       Impact factor: 8.192

7.  A translational silencing function of MCPIP1/Regnase-1 specified by the target site context.

Authors:  Gesine Behrens; Reinhard Winzen; Nina Rehage; Anneke Dörrie; Monika Barsch; Anne Hoffmann; Jörg Hackermüller; Christopher Tiedje; Vigo Heissmeyer; Helmut Holtmann
Journal:  Nucleic Acids Res       Date:  2018-05-04       Impact factor: 16.971

8.  MCP-induced protein 1 mediates the minocycline-induced neuroprotection against cerebral ischemia/reperfusion injury in vitro and in vivo.

Authors:  Zhuqing Jin; Jian Liang; Jing Wang; Pappachan E Kolattukudy
Journal:  J Neuroinflammation       Date:  2015-02-27       Impact factor: 8.322

9.  Roquin targets mRNAs in a 3'-UTR-specific manner by different modes of regulation.

Authors:  Katharina Essig; Nina Kronbeck; Joao C Guimaraes; Claudia Lohs; Andreas Schlundt; Anne Hoffmann; Gesine Behrens; Sven Brenner; Joanna Kowalska; Cristina Lopez-Rodriguez; Jacek Jemielity; Helmut Holtmann; Kristin Reiche; Jörg Hackermüller; Michael Sattler; Mihaela Zavolan; Vigo Heissmeyer
Journal:  Nat Commun       Date:  2018-09-19       Impact factor: 14.919

10.  ZC3H12A Expression in Different Stages of Colorectal Cancer.

Authors:  Tao Chen; Di Du; Jian Chen; Pinghong Zhou; John N Weinstein; Liqing Yao; Yuexin Liu
Journal:  Oncoscience       Date:  2019-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.